A Study to Learn How Safe, Tolerable and Capable of Producing an Immune Response is, a Modified RNA Vaccine Against Pandemic Influenza

Clinical trial NCT06179446 · COMPLETED

Trial details

NCT number: NCT06179446
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Grippe Influenza Vaccines

Start date: 2023-12-13
Primary completion: 2025-09-23
Enrollment: 157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.